22nd May 2009......
Johnson & Johnson has ventured into biotechnology domain with a late-stage oncology drug in its pipeline. For this deal J&J will pay $1 billion cash to Cougar Biotechnology, which has drugs in its pipeline for prostate cancer, breast cancer and multiple myeloma. Cougar will work with Ortho Biotech Oncology R&D, a unit of Centocor R&D.
21st May 2009,
A new biotech start-up formed by collaboration of ex management team of Pharmion,who last year sold their venture to Celgendsne for $2.9 Billion, It includes domian associates, angel investors, venture funds, proquest investment.
The partnership lined up is worth $145 Million and the company is into early-stage cancer projects and will follow the old business plan of Pharmion.
21st May 2009.....
Lonza Swiss drug maker is going to invest around $ 150 Million in Hyderabad, India in genome valley SEZ and Phase II Biotech Park for R&D and bio-pharmaceutical manufacturing facility.this will be the biggest venture till date in biopharmaceuticals in india.
No comments:
Post a Comment